BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24986606)

  • 21. Histone deacetylase inhibitor uses p21(Cip1) to maintain anergy in CD4+ T cells.
    Dagtas AS; Edens RE; Gilbert KM
    Int Immunopharmacol; 2009 Oct; 9(11):1289-97. PubMed ID: 19664724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histone acetylation regulates both transcription initiation and elongation of hsp22 gene in Drosophila.
    Zhao Y; Lu J; Sun H; Chen X; Huang W; Tao D; Huang B
    Biochem Biophys Res Commun; 2005 Jan; 326(4):811-6. PubMed ID: 15607742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transient vs. prolonged histone hyperacetylation: effects on colon cancer cell growth, differentiation, and apoptosis.
    Wu JT; Archer SY; Hinnebusch B; Meng S; Hodin RA
    Am J Physiol Gastrointest Liver Physiol; 2001 Mar; 280(3):G482-90. PubMed ID: 11171632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer.
    Mariadason JM; Corner GA; Augenlicht LH
    Cancer Res; 2000 Aug; 60(16):4561-72. PubMed ID: 10969808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV-1 reactivation induced by apicidin involves histone modification in latently infected cells.
    Lin S; Zhang Y; Ying H; Zhu H
    Curr HIV Res; 2011 Jun; 9(4):202-8. PubMed ID: 21631428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C/EBPα and PU.1 are involved in distinct differentiation responses of acute promyelocytic leukemia HL-60 and NB4 cells via chromatin remodeling.
    Savickiene J; Treigyte G; Vistartaite G; Tunaitis V; Magnusson KE; Navakauskiene R
    Differentiation; 2011 Jan; 81(1):57-67. PubMed ID: 20864248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Keratin 23 (K23), a novel acidic keratin, is highly induced by histone deacetylase inhibitors during differentiation of pancreatic cancer cells.
    Zhang JS; Wang L; Huang H; Nelson M; Smith DI
    Genes Chromosomes Cancer; 2001 Feb; 30(2):123-35. PubMed ID: 11135429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p21 gene regulation during enterocyte differentiation.
    Archer SY; Johnson JJ; Kim HJ; Hodin RA
    J Surg Res; 2001 Jun; 98(1):4-8. PubMed ID: 11368530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HDAC inhibitors TSA and sodium butyrate enhanced the human IL-5 expression by altering histone acetylation status at its promoter region.
    Han S; Lu J; Zhang Y; Cheng C; Li L; Han L; Huang B
    Immunol Lett; 2007 Feb; 108(2):143-50. PubMed ID: 17270283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A].
    Yoshida M
    Tanpakushitsu Kakusan Koso; 2007 Oct; 52(13 Suppl):1788-9. PubMed ID: 18051427
    [No Abstract]   [Full Text] [Related]  

  • 31. Acetylation of the Entamoeba histone H4 N-terminal domain is influenced by short-chain fatty acids that enter trophozoites in a pH-dependent manner.
    Byers J; Eichinger D
    Int J Parasitol; 2008 Jan; 38(1):57-64. PubMed ID: 17706222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-wide screening for target regions of histone deacetylases in cardiomyocytes.
    Kaneda R; Ueno S; Yamashita Y; Choi YL; Koinuma K; Takada S; Wada T; Shimada K; Mano H
    Circ Res; 2005 Aug; 97(3):210-8. PubMed ID: 16002748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HDAC inhibitors sodium butyrate and sodium valproate do not affect human ncor1 and ncor2 gene expression in HL-60 cells.
    Vrba J; Trtkova K; Ulrichova J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Sep; 155(3):259-62. PubMed ID: 22286811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carboxypeptidase A3 (CPA3): a novel gene highly induced by histone deacetylase inhibitors during differentiation of prostate epithelial cancer cells.
    Huang H; Reed CP; Zhang JS; Shridhar V; Wang L; Smith DI
    Cancer Res; 1999 Jun; 59(12):2981-8. PubMed ID: 10383164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histone deacetylase inhibitors induce apoptosis in peripheral blood lymphocytes along with histone H4 acetylation and the expression of the linker histone variant, H1 degrees.
    Sourlingas TG; Tsapali DS; Kaldis AD; Sekeri-Pataryas E
    Eur J Cell Biol; 2001 Nov; 80(11):726-32. PubMed ID: 11824792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of PIG3 and NOXA through acetylation of p53 at 320 and 373 lysine residues as a mechanism for apoptotic cell death by histone deacetylase inhibitors.
    Terui T; Murakami K; Takimoto R; Takahashi M; Takada K; Murakami T; Minami S; Matsunaga T; Takayama T; Kato J; Niitsu Y
    Cancer Res; 2003 Dec; 63(24):8948-54. PubMed ID: 14695212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apicidin, a novel histone deacetylase inhibitor, has profound anti-growth activity in human endometrial and ovarian cancer cells.
    Ueda T; Takai N; Nishida M; Nasu K; Narahara H
    Int J Mol Med; 2007 Feb; 19(2):301-8. PubMed ID: 17203205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SKW 6.4 cell differentiation induced by interleukin 6 is stimulated by butyrate.
    Kawamoto T; Gohda E; Iji H; Fujiwara M; Yamamoto I
    Immunopharmacology; 1998 Aug; 40(2):119-30. PubMed ID: 9826026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells.
    Sonnemann J; Kumar KS; Heesch S; Müller C; Hartwig C; Maass M; Bader P; Beck JF
    Int J Oncol; 2006 Mar; 28(3):755-66. PubMed ID: 16465382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The novel histone deacetylase inhibitor BML-210 exerts growth inhibitory, proapoptotic and differentiation stimulating effects on the human leukemia cell lines.
    Savickiene J; Borutinskaite VV; Treigyte G; Magnusson KE; Navakauskiene R
    Eur J Pharmacol; 2006 Nov; 549(1-3):9-18. PubMed ID: 16978604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.